March 23, 2018 / 1:42 AM / 6 months ago

BRIEF-‍Amicus Therapeutics Announces Approval Of Galafold For Fabry Disease In Japan​

March 22 (Reuters) - Amicus Therapeutics Inc:

* ‍AMICUS THERAPEUTICS ANNOUNCES APPROVAL OF GALAFOLD® (MIGALASTAT) FOR FABRY DISEASE IN JAPAN​

* ‍ANTICIPATES LAUNCHING GALAFOLD IN JAPAN IN COMING MONTHS​

* ‍WILL NOW PROCEED WITH PRICING AND REIMBURSEMENT PROCESSES​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below